The patent on Ozempic in Australia doesn’t expire til 2029. In the meantime, Canada and India get cheap generics while Australians will pay full price for a brand name
This is the real problem: "There were an extraordinary 420,000 people receiving a private-market supply of GLP-1 agonist drugs semaglutide or tirzepatide as of mid-last year". Why accept a lower wholesale price on the PBS when half a million people are paying full price? Time to bring on generics.